#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Lymphoma Colitis ulcerative Acute myeloid leukaemia refractory Cholestatic pruritus Acute hepatic failure Complex regional pain syndrome Fragile X syndrome Astrocytoma KBG syndrome VEXAS syndrome Mucopolysaccharidosis II Basal cell naevus syndrome Congenital ectodermal dysplasia Leukocyte adhesion deficiency type I Adult T-cell lymphoma/leukaemia refractory More trials…

    Learn about Rare Diseases

    Soft tissue sarcoma – Basic Information Splenic marginal zone lymphoma – Trials in Disease Choroid melanoma – Trials in Disease Acquired haemophilia – Life with Disease Lymphangioma – Basic Information Mantle cell lymphoma stage IV – Treatment Hepatic angiosarcoma – Diagnostics Arterial tortuosity syndrome – Basic Information Breast angiosarcoma metastatic – Life with Disease Gaucher’s disease type III – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Pantothenate Sodium HYDROMORPHONE HYDROCHLORIDE Cangrelor Tetrasodium Gallium (68Ga) Psma-R2 Censavudine Emraclidine Amphotericine B, Liposome Mesenchymal Cells A/H1N1 INFLUENZA VACCINE Izokibep Pasireotide Pramipexole Midostaurin Rimegepant Interferon Beta-1B Dulaglutide Miglustat HYPOCHLOROUS ACID S-241656 Fitusiran More therapies…

    Learn about Your Condition

    Rectal adenocarcinoma Hepatoblastoma Craniosynostosis Breast angiosarcoma Meniere's disease Neurofibrosarcoma Behavioural addiction Staphylococcal infection Hypochromic anaemia Eye pain Diabetic retinopathy Inflammatory bowel disease Back pain B-cell lymphoma refractory Biopsy heart More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Thermal burn

  • Study of dexamethasone effectiveness in reducing complications and mortality in patients with severe burns

    Recruiting

    3 1 1
    Investigated Diseases:
    • Thermal burn
    Investigated Drugs:
    • Dexamethasone Phosphate
    • Sodium Chloride
    France

  • Study on the Effectiveness of EHSG-KF Skin Graft for Patients with Deep Partial and Full-Thickness Burns

    Recruiting

    3 1 1
    Investigated Drugs:
    • Bilayer Engineered Collagen Hydrogel-Based Skin Graft Composed Of Autologous Keratinocytes And Fibroblasts
    Belgium France Germany Italy The Netherlands Poland +2

  • Study on Antibiotic Prophylaxis with Piperacillin, Tazobactam, and Cefazolin for Burn Patients Undergoing Excision-Graft Surgery

    Recruiting

    3 1 1
    Investigated Diseases:
    • Thermal burn
    Investigated Drugs:
    • Cefazolin
    • Piperacillin Sodium
    • Tazobactam Sodium
    France

  • Study on Glucose Use in Adults with Severe Burns

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Thermal burn
    Investigated Drugs:
    • Glucose
    France

  • Study on Tranexamic Acid and Sodium Chloride for Reducing Blood Loss in Patients Undergoing Burn Surgery

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Thermal burn
    Investigated Drugs:
    • Tranexamic Acid
    • Sodium Chloride
    The Netherlands

  • Study on the Effects of High-Dose Vitamin C in Patients with Severe Burns

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Thermal burn
    Investigated Drugs:
    • Ascorbic Acid
    Belgium France Germany Italy Portugal
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!